SALT LAKE CITY--(BUSINESS WIRE)--Q Therapeutics, Inc. announced today that it and Nicholas Maragakis, MD of Johns Hopkins University had received notification of an $800,000 grant to be awarded from the Maryland Stem Cell Research Fund (MSCRF) to enable study of Q’s human neural cell product Q-Cells® in preclinical models of Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s Disease). Nicholas Maragakis, MD, is an Associate Professor of Neurology at Johns Hopkins and is the Principal Investigator. James Campanelli, Ph.D., Senior Director of Research and Development at Q is Co-Investigator on the grant.
